e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Pathobiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Long noncoding RNA H19 in the pathogenesis of right ventricular failure with pulmonary arterial hypertension
J. Omura (Quebec city, Canada), S. Breuils-Bonnet (Quebec city, Canada), O. Boucherat (Quebec city, Canada), S. Provencher (Quebec city, Canada), S. Bonnet (Quebec city, Canada)
Source:
International Congress 2018 – Pathobiology of pulmonary hypertension
Session:
Pathobiology of pulmonary hypertension
Session type:
Poster Discussion
Number:
3933
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Omura (Quebec city, Canada), S. Breuils-Bonnet (Quebec city, Canada), O. Boucherat (Quebec city, Canada), S. Provencher (Quebec city, Canada), S. Bonnet (Quebec city, Canada). Long noncoding RNA H19 in the pathogenesis of right ventricular failure with pulmonary arterial hypertension. 3933
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Epigenetic signature of right ventricular failure in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension
Source: Eur Respir J, 53 (4) 1900255; 10.1183/13993003.00255-2019
Year: 2019
Evaluation of acute right ventricular failure in scleroderma and idiopathic pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
Prolonged overcirculation-induced pulmonary arterial hypertension, as a cause of right ventricular failure
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011
Left atrial volume to distinguish idiopathic pulmonary arterial hypertension from pulmonary hypertension due to left heart disease
Source: Annual Congress 2011 - Clinical features of human pulmonary hypertension
Year: 2011
Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2013; 41: 224-232
Year: 2013
Native myocardial T1 correlates with right ventricular remodelling in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Increased right ventricular cardiomyocyte stiffness in patients with pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and cell biology
Year: 2012
Impaired right ventricular diastolic function in systemic sclerosis-associated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary vascular medicine
Year: 2008
The role of the right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 243-253
Year: 2011
Right ventricular stiffness impairs right atrial function in pulmonary arterial hypertension
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020
Right ventricular and pulmonary vascular interaction in pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension in connective tissue diseases
Year: 2008
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension
Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019
Year: 2021
Association of renal dysfunction with cardiac output and right atrial pressure in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2008; 31: 1160-1166
Year: 2008
Load-independent right ventricular function and idiopathic pulmonary arterial hypertension severity
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Pulmonary hypertension in left heart disease
Source: Eur Respir Rev 2012 21: 338-346
Year: 2012
Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Differences of right ventricular diastolic stiffness in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept